Site-Neutral
AHA comments regarding the ongoing government funding discussion, AHA Urges Congress to eliminate Medicaid DSH cuts, reject Site-neutral payments.
While Medicare has historically reimbursed hospitals below the cost of providing care to patients, new data shows that Medicare payment levels hit record lows in 2022.
The AHA’s Site-neutral Advocacy Alliance will meet on Thursday, Jan. 11 at 1 p.m. ET. This call will feature updates on site-neutral provisions moving through Congress and next steps. Register for the Jan. 11 call here.
The House Dec. 11 voted 320-71 to pass legislation (H.R. 5378) that would delay a Jan. 19 payment reduction to Medicaid disproportionate share hospitals for two years, but permanently reduce Medicare payments for drug administration services in off-campus hospital outpatient departments.
The AHA today urged members of the House of Representatives to oppose H.R. 5378, legislation scheduled to be voted on tonight, unless site-neutral provisions are removed from the bill.
While the AHA appreciates inclusion of a two-year delay on DSH cuts, we have been very clear regarding the harm that would be done to our nation’s hospitals if so-called site-neutral cuts to Medicare were adopted. We have strongly urged that those cuts be eliminated from this legislation.
NEW: National and State Impacts of Site-neutral Provisions in the Lower Costs, More Transparency Act (H.R. 5378
The House of Representatives as soon as next week could consider the Lower Costs, More Transparency Act (H.R. 5378), a bill that includes site-neutral payment cuts and detrimental provisions focused on hospital price transparency, among other issues.
The AHA and American Society of Health-System Pharmacists Nov. 14 urged House and Senate leaders to oppose any policies that fail to take into account the costs of safely providing drug administration services to the complex patients that hospitals serve.
The American Hospital Association and American Society of Health-System Pharmacists express concerns that proposed site-neutral legislation in the House and Senate could reduce access to patient care and jeopardize patient safety.